Frequency of morning ketosis after overnight insulin suspension using an automated nocturnal predictive low glucose suspend system

Diabetes Care

Volumn 37, Issue 5, 2014, Pages 1224-1229

  Beck, Roy W ^a   Raghinaru, Dan ^a   Wadwa, R Paul ^b   Chase, H Peter ^b   Maahs, David M ^b   Buckingham, Bruce A ^c  

^a JAEB CENTER FOR HEALTH RESEARCH   (United States)

^b UNIVERSITY OF COLORADO DENVER   (United States)

^c STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; KETONE; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL;

ADOLESCENT; ADULT; ARTICLE; AUTOMATION; BLOOD ANALYSIS EQUIPMENT; BLOOD GLUCOSE METER; BLOOD GLUCOSE MONITORING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE SENSOR; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; KETOACIDOSIS; MALE; RANDOMIZED CONTROLLED TRIAL (TOPIC); BLOOD; CIRCADIAN RHYTHM; CLINICAL TRIAL; DIABETES MELLITUS, TYPE 1; INSULIN INFUSION; KETOSIS; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; OUTPATIENT; PATHOPHYSIOLOGY; PHYSIOLOGY; PREDICTIVE VALUE; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; SELF CARE; URINE; YOUNG ADULT;

ADOLESCENT; ADULT; BLOOD GLUCOSE; CIRCADIAN RHYTHM; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; KETONES; KETOSIS; MALE; MIDDLE AGED; OUTPATIENTS; PREDICTIVE VALUE OF TESTS; PREVALENCE; SELF CARE; YOUNG ADULT;

EID: 84899114951     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc13-2775     Document Type: Article

References (17)

1. Attia N, Jones TW, Holcombe J, Tamborlane WV. Comparison of human regular and lispro insulins after interruption of continuous subcutaneous insulin infusion and in the treatment of acutely decompensated IDDM. Diabetes Care 1998;21:817-821 (Pubitemid 28487078)
2. Castillo MJ, Scheen AJ, Lefèbvre PJ. The degree/rapidity of the metabolic deterioration following interruption of a continuous subcutaneous insulin infusion is influenced by the prevailing blood glucose level. J Clin Endocrinol Metab 1996;81:1975-1978 (Pubitemid 26152494)
3. Tsalikian E, Kollman C, Tamborlane WB, et al.; Diabetes Research in Children Network (DirecNet) Study Group. Prevention of hypoglycemia during exercise in children with type 1 diabetes by suspending basal insulin. Diabetes Care 2006;29:2200-2204 (Pubitemid 44899852)
4. Guerci B, Benichou M, Floriot M, et al. Accuracy of an electrochemical sensor for measuring capillary blood ketones by fingerstick samples during metabolic deterioration after continuous subcutaneous insulin infusion interruption in type 1 diabetic patients. Diabetes Care 2003;26:1137-1141 (Pubitemid 36929261)
5. Krzentowski G, Scheen A, Castillo M, Luyckx AS, Lefèbvre PJ. A 6-hour nocturnal interruption of a continuous subcutaneous insulin infusion: 1. Metabolic and hormonal consequences and scheme for a prompt return to adequate control. Diabetologia 1983;24:314-318 (Pubitemid 13092213)
6. Orsini-Federici M, Akwi JA, Canonico V, et al. Early detection of insulin deprivation in continuous subcutaneous insulin infusion-treated patients with type 1 diabetes. Diabetes Technol Ther 2006;8:67-75
7. Pickup JC, Viberti GC, Bilous RW, et al. Safety of continuous subcutaneous insulin infusion: metabolic deterioration and glycaemic autoregulation after deliberate cessation of infusion. Diabetologia 1982;22:175-179 (Pubitemid 12183675)
8. Sherr JL, Collazo MP, Cengiz E, et al. Safety of nighttime 2-hour suspension of basal insulin in pump-treated type 1 diabetes even in the absence of low glucose. Diabetes Care. 29 October 2013 [Epub ahead of print]
9. Cengiz E, Xing D, Wong JC, et al.; T1D Exchange Clinic Network. Severe hypoglycemia and diabetic ketoacidosis among youth with type 1 diabetes in the T1D Exchange clinic registry. Pediatr Diabetes 2013;14:447-454
10. Weinstock RS, Xing D, Maahs DM, et al.; T1D Exchange Clinic Network. Severe hypoglycemia and diabetic ketoacidosis in adults with type 1 diabetes: results from the T1D Exchange clinic registry. J Clin Endocrinol Metab 2013;98:3411-3419
11. Maahs DM, Beck RW, Buckingham BA, et al. A Randomized Trial of a Home System to Reduce Nocturnal Hypoglycemia in Type 1 Diabetes. Late-breaking abstract presented at the 2013 Diabetes Technology Meeting, San Francisco, CA, 1 November 2013
12. Bergenstal RM, Klonoff DC, Garg SK, et al.; ASPIRE In-Home Study Group. Threshold-based insulin-pump interruption for reduction of hypoglycemia. N Engl J Med 2013;369:224-232
13. Buckingham BA, Cameron F, Calhoun P, et al. Outpatient safety assessment of an in-home predictive low-glucose suspend system with type 1 diabetes subjects at elevated risk of nocturnal hypoglycemia. Diabetes Technol Ther 2013;15:622-627
14. Choudhary P, Shin J, Wang Y, et al. Insulin pump therapy with automated insulin suspension in response to hypoglycemia: reduction in nocturnal hypoglycemia in those at greatest risk. Diabetes Care 2011;34:2023-2025
15. Danne T, Kordonouri O, Holder M, et al. Prevention of hypoglycemia by using low glucose suspend function in sensor-augmented pump therapy. Diabetes Technol Ther 2011;13:1129-1134
16. Ly TT, Nicholas JA, Retterath A, Davis EA, Jones TW. Analysis of glucose responses to automated insulin suspension with sensor-augmented pump therapy. Diabetes Care 2012;35:1462-1465
17. Ly TT, Nicholas JA, Retterath A, Lim EM, Davis EA, Jones TW. Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial. JAMA 2013;310:1240-1247 Diseases